Key result
Anesthesia for MVR in nonobstructive HCM with severe PH poses significant hemodynamic challenges.
Case Report (n=1)
Highlights the complex hemodynamic challenges in anesthetic management for patients with HCM and severe valvular disease undergoing cardiac surgery.
Demands vigilant hemodynamic monitoring for MVR in nonobstructive HCM with severe PH; case reports leave open standardized protocols from prospective data.
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle with preserved or increased ejection fraction. Mitral regurgitation is common in HCM secondary to distortion of mitral valve apparatus leading to systolic anterior motion. We report a case of HCM with rheumatic involvement of mitral valve with severe pulmonary artery hypertension and atrial fibrillation. With regard to hemodynamic management in patients with postcardiac surgery status, anesthetic management seems to be a “walk a tight rope.”
No takes yet. Share an insight, caveat, or question.
Nikhil N. Mudgalkar (2021) conducted a case report in Hypertrophic cardiomyopathy with severe mitral regurgitation and severe pulmonary artery hypertension (n=1). Anesthesia management was evaluated. Anesthetic management for mitral valve replacement in a patient with nonobstructive hypertrophic cardiomyopathy and severe pulmonary hypertension is hemodynamically challenging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: